Episodes of depression with attempted suicide after taking valsartan and hydrochlorothiazide;Depressive Episode mit Suizidversuch nach Einnahme von Valsartan mit Hydrochlorothiazid

Deutsche Medizinische Wochenschrift

Volumn 128, Issue 48, 2003, Pages 2534-2536

  Ullrich, H ^a,b   Passenberg, P ^b   Agelink, M W ^a  

^a Klinik für Psychiatrie Neurologie Psychosomatik und Psychotherapie im Kindes und Jugendalter   (Germany)

^b Evangelische Kliniken Gelsenkirchen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; HYDROCHLOROTHIAZIDE PLUS VALSARTAN; METOPROLOL;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BRAIN SCINTISCANNING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR DEPRESSION; MOOD DISORDER; MORBIDITY; NEUROLOGIC EXAMINATION; PHYSICAL EXAMINATION; PSYCHIATRIC DIAGNOSIS; SUICIDE ATTEMPT; SYMPTOMATOLOGY;

ADULT; ANTIHYPERTENSIVE AGENTS; DEPRESSION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; SUICIDE, ATTEMPTED; TETRAZOLES; VALINE;

EID: 0344303556     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-44949     Document Type: Article

References (15)

1. Agelink MW, Boz C, Ullrich H, Andrich J. Relationship between major depression and heart rate variability: Clinical consequences and implications for antidepressive treatment. Psychiatry Res 2002; 113: 139-149
2. Ahmad S. Losartan and reversible psychosis. Cardiology 1996; 87: 569-570
3. Balt JC, Mathy MJ, Pfaffendorf M, van Zwieten PA. Sympatho-inhibitory properties of various AT1 receptor antagonists. J Hypertens 2002; 20(Suppl 5); S3-11
4. Benz JR, Black HR, Graff A et al. Valsartan and hydrochlorothiazide in patients with essential hypertension. A multiple dose, double-blind placebo controlled trial comparing combination therapy with monotherapy. J Hum Hypertens 1998; 12: 861-866
5. Bertram D, Coote JH. Inhibitory effects of angiotensin II on barosensitive rostral ventrolateral medulla neurons of the rat. Clin Exp Pharmacol Physiol 2001; 28: 1112-1114
6. Black HR, Graff A, Shute D et al. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril. J Hum Hypertens 1997; 11: 483-489
7. Deuschle M, Lederbogen F, Borggrefe M et al. Erhöhtes kardiovaskuläres Risiko bei depressiven Patienten. Dtsch Arztebl 2002; 99: A 3332-3338
8. Kohn R. Beta-Blockers an important cause of depression: a medical myth without evidence. Med Health R I 2001; 84: 92-95
9. Long TD, Kathol RG. Critical review of data supporting affective disorder caused by nonpsychotropic medication. Ann Clin Psychiatry 1993; 5: 259-257
10. Mesure G, Fallet A, Chevalier JF. Psychotropic effects of angiotensin-converting enzyme inhibitors: what are the arguments? Encephale 1995; 21: 609-614
11. Okada F. Depression after treatment with thiazide diuretics for hypertension. Am J Psychiatry 1985; 142: 1101-1102
12. Patten SB, Love EJ. Drug-induced depression: Incindence, avoidance and management. Drug Saf 1994; 10: 203-219
13. Rasanen P, Hakko H, Tiihonen J. Pindolol and major affective disorders: a three-year follow-up study of 30,485 patients. J Clin Psychopharmacol 1999; 19: 297-302
14. Schildkraut JJ. The catecholamine hypothesis of affective disorders. A review of supporting evidence. Am J Psychiatry 1965; 122: 509-522
15. Weisser B, Vetter H, Mengden T. Blutdrucksenkung, Blutdruckamplitude und Herzfrequenz unter Therapie mit Valsartan oder Valsartan/ Hydrochlorothiazid. Dtsch Med Wochenschr 2003; 128: 541-544